Yahoo Finance • 14 days ago
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows BERKELEY, Calif, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the... Full story
Yahoo Finance • 21 days ago
Internationally recognized vascular surgeon, Dr. Koen Deloose provides patient access to latest innovative treatments and personalized care BERKELEY, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”)... Full story
Yahoo Finance • 29 days ago
Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs BERKELEY, Calif, Aug. 27, 2025 (GLOBE NEWSW... Full story
Yahoo Finance • 30 days ago
Profusa, Inc. (NASDAQ:PFSA), a microcap company with a market value of $16.48 million, announced Monday that it has amended its Securities Purchase Agreement and Senior Secured Convertible Promissory Note with Ascent Partners Fund LLC, ori... Full story
Yahoo Finance • last month
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black & Decker, and DuPont Berkel... Full story
Yahoo Finance • 2 months ago
BERKELEY - Profusa, Inc. (NASDAQ:PFSA), a digital health company focused on continuous biochemistry monitoring technology, outlined its growth strategy following its recent Nasdaq listing on July 14, according to a shareholder letter relea... Full story
Yahoo Finance • 2 months ago
BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monito... Full story
Yahoo Finance • 2 months ago
BERKELEY, Calif, July 31, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitor... Full story
Yahoo Finance • 2 months ago
BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monito... Full story